GSTM1 and diffuse large B-cell lymphoma: Furthermore, Matsumoto et al., proposed a simple prognostic index based on grade 2 anemia (defined as Hb < 100–80 g/L) and advanced Ann Arbor clinical stages (CS) to predict outcome in DLBCL patients [194].